journal article·2026-06Open access

Proactive gliding-nanomachines declined tumor autophagy for enhanced tumor death

Ling Zhang, Yongsheng Du, Rui Gao, Yu Dong, Miaomiao Zhang, Qiaoyun Wang, Fei Tong, Weiwei Qiao

Abstract

Autophagy was associated with the pathophysiology of various diseases in vivo , and its own regulation was beneficial for the outcomes of specific diseases. Here, we successfully designed a biocompatible active gliding-nanomachine for delivery of chloroquine (CQ)/nanodiamond (ND) and accelerated tumor cell death associated with amplifying ferroptosis and declining autophagy in vitro . Fe was covered onto one side of the surface of the L-arg@CQ/ND@HA, functioning as a controller for the dominated release of NO by sensitive ROS and Fenton-reaction from the catalyzation between Fe 2+ and H 2 O 2 in vitro . The asymmetrical NO release, which was not only the active-component to decline tumor autophagy in combination with ND/CQ, but also the propellants for the nanomachines. After implementing in tumor cell, the dynamic-sliding of nanomachines could be triggered via ROS and the proactive-gliding further strengthened diffusion of CQ/ND, leading to precise-treatment of tumors through enlarging ferroptosis accompanied by polyamine output and interruption of autophagosome lysosome fusion. The synthetized dynamic sliding-nanomachines, with ROS stimulation of movement behavior and proactive delivery of CQ/ND unlocked huge latent capacity as a potential platform for tumor treatment stemed from ferroptosis amplification loop induced polyamine output and declining autophagy in tumor cell. Lin Zhang et al. developed a active gliding - nanomachine (Fe@L-arg@CQ/ND@HA) that could enhance tumor treatment by declining tumor autophagy and amplifying ferroptosis accompanied by polyamine output. These distinctive-nanomachines dramatically accelerated tumor cell death through chloroquine (CQ) synergism nanodiamond (ND). • Fe@L-arg@CQ/ND@HA-nanomachines executed gliding by asymmetric NO release. • Fe 2+ catalyzed H 2 O 2 to produce •OH via Fenton-reaction. • Fe 3+ overload mediated polyamine output to amplify ferroptosis. • Released NO restrained tumor autophagy in combination with CQ/ND.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Autophagy in Disease and Therapy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Inhibiting cytoprotective autophagy in cancer therapy: an update on pharmacological small-molecule compounds
2. How autophagy controls the intestinal epithelial barrier10.1080/15548627.2021.1909406 ↗
3. Targeting autophagy in cancer10.1038/nrc.2017.53 ↗
4. The different autophagy degradation pathways and neurodegeneration10.1016/j.neuron.2022.01.017 ↗
5. Autophagy in the pathogenesis of disease10.1016/j.cell.2007.12.018 ↗
6. Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors10.1038/s41467-018-06749-2 ↗
7. Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagy10.1016/j.actbio.2022.12.059 ↗
8. Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention10.1007/978-3-030-43032-0_15 ↗
9. Checkpoint inhibitor hepatotoxicity: pathogenesis and management10.1097/HEP.0000000000000045 ↗
10. Toxicities associated with immune checkpoint inhibitors: a systematic study10.1097/JS9.0000000000000368 ↗
11. Review targeted drug delivery systems for norcantharidin in cancer therapy10.1186/s12951-022-01703-3 ↗
12. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma10.1016/j.actbio.2020.04.009 ↗
13. Tailored chemodynamic nanomedicine improves pancreatic cancer treatment via controllable damaging neoplastic cells and reprogramming tumor microenvironment10.1021/acs.nanolett.0c02622 ↗
14. H2S-powered nanomotors for active therapy of tumors by inducing ferroptosis and lactate-pyruvate axis disorders10.1021/acsbiomaterials.3c01665 ↗
15. Noncontinuous super-diffusive dynamics of a light-activated nanobottle motor10.1002/anie.201801910 ↗
16. Biosafety, functionalities, and applications of biomedical micro/nanomotors10.1002/anie.202013689 ↗
17. How safe are magnetic nanomotors: from cells to animals10.1016/j.bioadv.2022.213048 ↗
18. Biomedical micro-/nanomotors: from overcoming biological barriers to in vivo imaging10.1002/adma.202000512 ↗
19. Arthritic microenvironment actuated nanomotors for active rheumatoid arthritis therapy
20. Recent progress of micro/nanomotors to overcome physiological barriers in the gastrointestinal tract10.1016/j.jconrel.2023.07.005 ↗
21. pH/ROS-responsive propelled nanomotors for the active treatment of renal injury10.1039/D3NR00062A ↗
22. Biomimetic and NOS-responsive nanomotor deeply delivery a combination of MSC-EV and mitochondrial ROS scavenger and promote heart repair and regeneration
23. Oral nanomotor-enabled mucus traverse and tumor penetration for targeted chemo-sono-immunotherapy against colon cancer10.1002/smll.202203466 ↗
24. Bio-inspired nitric-oxide-driven nanomotor10.1038/s41467-019-08670-8 ↗
25. Fenton reaction induced by fe-based nanoparticles for tumor therapy10.1166/jbn.2021.3130 ↗
26. Metal-polyphenol-network coated prussian blue nanoparticles for synergistic ferroptosis and apoptosis via triggered GPX4 inhibition and concurrent in situ bleomycin toxification10.1002/smll.202103919 ↗
27. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms10.1016/j.phrs.2021.105582 ↗
28. In situ nitric oxide gas nanogenerator reprograms glioma immunosuppressive microenvironment
29. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer10.1038/s41467-024-46776-w ↗
30. Nanomachine-based flexible bubbles for alleviating long QT syndrome
31. Anisotropic truncated octahedral au with pt deposition on arris for localized surface plasmon resonance-enhanced photothermal and photodynamic therapy of osteosarcoma10.1021/acsami.1c07181 ↗
32. pH-responsive neutrophil membrane camouflage Ga-Mn bimetallic nanodecoy triggers apoptosis-immunity-metastasis suppression for tumor therapy10.1016/j.biomaterials.2025.123794 ↗
33. Active oxygen chemistry within the liposomal bilayer. Part IV: locating 2',7'-dichlorofluorescein (DCF), 2',7'-dichlorodihydrofluorescein (DCFH) and 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) in the lipid bilayer10.1016/j.chemphyslip.2004.04.006 ↗
34. Gal3-CaN-smurf1 complex sequestrates FLCN-FNIPs to facilitate TFEB activation in response to endomembrane damage
35. Killing cancer cells by rupturing their lysosomes10.1038/s41565-020-0639-z ↗
36. Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells10.1038/s41565-020-0643-3 ↗
37. Strategies for enhancing the heterogeneous fenton catalytic reactivity:a review10.1016/j.apcatb.2019.05.041 ↗
38. A strategy of fenton reaction cycloacceleration for high-performance ferroptosis therapy initiated by tumor microenvironment remodeling10.1002/adhm.202203362 ↗
39. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions10.1016/j.ccell.2024.03.011 ↗
40. A diversity of selective autophagy receptors determines the specificity of the autophagy pathway10.1016/j.molcel.2019.09.005 ↗
41. MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA110.1097/CM9.0000000000002569 ↗
42. Aloperine suppresses cancer progression by interacting with VPS4A to inhibit autophagosome-lysosome fusion in NSCLC
43. The emerging potential role of p62 in cancer treatment by regulating metabolism10.1016/j.tem.2023.05.004 ↗